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ABSTRACT 
 
HIV incidence and prevalence rates for US women continue to increase, 
especially among Black and Latina women. In addition, the link between 
violence and HIV acquisition has been well documented. However, the 
interaction between violence, HIV risk, and HIV acquisition remains an 
under-addressed issue in current clinical and behavioral HIV research designs. 
Because violence against women plays an important role in HIV acquisition 
and transmission, it is imperative for clinical research to address violence in 
trial design and implementation. In this article, we discuss the prevalence of 
violence in women’s lives; the role violence plays in HIV acquisition; and the 
absence of violence in clinical research designs. We conclude with 
recommendations for integrating concerns about HIV and violence against 
women into sponsor- and investigator-driven HIV research priorities and 
clinical trial design. 
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INTRODUCTION 
In recent years, HIV incidence rates for U.S. women have quietly risen, 
especially among women of color (CDC, 2011).  Although few women were 
impacted in the early epidemic, rates have skyrocketed in recent years. According 
to the U.S. Centers for Disease Control and Prevention’s (CDC) 2011 surveillance 
data, adult and adolescent women make up a quarter of individuals living with 
HIV in the United States. Black and Latina women are hardest hit by the HIV 
epidemic, with dramatically disproportionate prevalence and incidence rates in 
these communities (CDC, 2011).  Results from the HIV Prevention Trials 
Network (HPTN)’s 2012 “Isis Study” (HPTN 064) illustrate this racial disparity. 
The Isis Study found that HIV rates among Black women in the northeast and 
southeast U.S. are five times higher than the CDC had previously estimated. HIV 
rates in these communities were comparable to rates in parts of sub-Saharan 
Africa.1  
Violence plays a very real role in many women’s lives. The World Health 
Organization (WHO) reports that globally, over one-third of women have 
experienced some form of physical or sexual violence (WHO, 2013). In addition, 
at least 15 percent of adult women have experienced sexual violence.  In some 
geographic areas prevalence rates of lifetime physical and/or sexual violence by 
an intimate partner are as high as 71 percent (WHO, 2004).  In the U.S., one in 
five women (18.3%) report having been raped at some time in their lives. Of these 
women, more than half (51.1%) reported that the rape was committed by an 
intimate partner, and 40.8% reported being raped by an acquaintance (WHO, 
2004).  Recent social and behavioral data on HIV risk provides evidence for a 
strong relationship between violence and HIV acquisition.2 Rape removes 
womens’ choice to engage in consensual sex and to use a condom for protection 
during sex (Zierler, 1996).  In addition, it greatly increases the risk for HIV 
transmission due to vaginal and/or rectal tearing (Slaughter, 1997). In response, 
the US government, non-governmental organizations, and community-based care 
providers formed several work groups and task forces to begin to address and 
remediate this issue.3 President Obama’s Working Group on the Intersection of 
HIV/AIDS, Violence Against Women and Girls, and Gender-related Health 
                                               
1
 Note: For press release on the ISIS study, brochures, and other study 
information: http://hptn.orresearch_studies/HPTN064Media.asp 
2
 Note: (Campbell, 2012); (Cavenaugh, 2010);( Dunkle, 2004); (Garcia-Moreno, 
2000); (Jewes, 2003); (Maman, 2002); (McDonnell, 2005); (Wyatt, 2002); 
(Zierler, 1996). 
3
 See: Working Group on the Intersection of HIV/AIDS, Violence Against 
Women and Girls, and Gender-related Health Disparities; UN Inter-Agency Task 
Force on Violence Against Women; UNAIDS Inter-Agency Task Team on 
Gender and HIV/AIDS; Global Commission on HIV and the Law; Greentree 
Meeting on Sexual Violence and HIV. 
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Disparities provides just one example of this type of working group.4  Efforts like 
these are a step in the right direction to glean a better understanding of the 
complex relationships between violence against women and HIV, which could 
hopefully lead to effective interventions that reduce HIV rates in women. 
While work groups and task forces are important components of ending 
violence against women, the Women’s HIV Research Collaborative (WHRC) 
believes that clinical and behavioral research also plays a critical role in 
addressing this issue. Clinical and behavioral research can answer important 
questions about transmission, prevention, and treatment of HIV. The NIH 
HIV/AIDS Clinical Trials Networks are currently structured to address questions 
related to prevention (HIV Prevention Trials Network, or HPTN), HIV vaccines 
(HIV Vaccine Trials Network, or HVTN), treatment (AIDS Clinical Trials Group, 
or ACTG), maternal-child transmission and treatment (International Maternal 
Pediatric Adolescent AIDS Clinical Trials Group, or IMPAACT), and 
microbicide research (Microbicide Trials Network, or MTN). Clinical and 
behavioral research design includes an initial screening visit followed by 
numerous study visits for clinical testing, treatment, monitoring, and/or 
observational data collection. Presently, violence is not always included in 
screening, intake, or visit questionnaires. The WHRC feels that this is a missed 
opportunity for important data collection about the role of violence in women’s 
lives.  
Although the WHRC’s primary relationship is with the NIH HIV/AIDS 
Clinical Trials Networks, we encourage all sponsor- and investigator-driven HIV 
research to consider the role violence plays in the domestic HIV epidemic. We 
urge the HIV research community to frame violence not only as a behavioral or 
social issue, but also as a policy concern. Towards this end, we have prepared this 
position paper to review current mechanisms for capturing data on violence and to 
outline the need for clinical and behavioral researchers to continue exploring 
violence as a confounding factor in HIV acquisition. Our hope is that this paper 
can provide justification for the collection of data on violence in clinical and 
behavioral research, as well as be a resource for researchers and advocates 
working in the fields of violence prevention, HIV education and prevention, and 
women’s health more generally. Violence against Women and Risk for HIV 
 Violence against individual women is primarily categorized as domestic 
violence (DV) and/or intimate partner violence (IPV), while structural violence 
represents a larger category of violence against women as a gender group (WHO, 
2013). For the purposes of this white paper, we are using the United Nations’ 
definition of violence: “any act of gender-based violence that results in, or is 
likely to result in, physical, sexual or mental harm or suffering to women, 
including threats of such acts, coercion or arbitrary deprivation of liberty, whether 
occurring in public or in private life.” (United Nations, 1993). Structural violence 
                                               
4
 Note: http://www.whitehouse.gov/the-press-office/2012/03/30/presidential-
memorandum-establishing-working-group-intersection-hivaids- 
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represents larger social forces (e.g., governments, belief systems, or cultural 
practices) that place certain people, or groups of people, particularly women, at 
increased risk or disadvantage. Examples of structural violence include blaming 
women for rape, placing the burden of proof on women, and glorifying rape and 
violence against women (Farmer, 2006). Structural violence creates a climate of 
risk for domestic and interpersonal violence (Farmer, 2006). As we discuss below, 
all types of violence contribute to the HIV epidemic, however, sexual violence 
may be the easiest to link directly to risk for HIV acquisition. Therefore, sexual 
violence is an ideal place to start when crafting behavioral research questions. 
Nonetheless, even though it may be more difficult to tease out direct relationship 
between structural violence and HIV risk, this is an important area for further 
research.  
 The profound impact structural violence has on health disparities is well 
documented, and extensive research has been conducted on sexual violence 
against women, both domestically and internationally. Lane et al identify several 
pathways by which structural violence contributes to HIV infection: “community 
rates of infection, concurrent partnerships, and increased vulnerability” (Lane et 
al., 2004). Raiford et al highlight the high rates of dating violence in African 
American teens and call for the need to train clinicians on how to screen for this 
type of violence (Raiford et al., 2012). Data like these reveal the importance of 
considering violence—including structural violence—in both research and 
clinical practice. It is for these reasons that we argue for the collection of data on 
violence in clinical and behavioral research.  
 
RESULTS 
 Table 1 provides an overview of intimate partner and sexual violence in 
the U.S. from the CDC’s 2010 National Intimate Partner and Sexual Violence 
Survey (NISVS). Because violence against women is highly prevalent across 
racial groups, age groups, and ethnic groups, it is imperative for HIV research--
and all research that includes women as participants--to incorporate screening for 
violence and appropriate referral mechanisms into clinical and behavioral 
research designs.  Should these practices be incorporated into clinical and 
behavioral research designs, researchers will be better able to capture the realities 
of many women’s lives, and more fully identify mechanisms of HIV risk 
acquisition. In this section, we discuss intimate partner and sexual violence as 
they relate to HIV risk and acquisition.  
 At the intimate or interpersonal level, the presence or threat of violence 
can decrease a woman’s “ability to recognize risk [and] lower her self-esteem” 
(WHO, 2010, p.26). This, in turn, can decrease a woman’s decision-making 
power to negotiate condom use (p.17). Even without the presence or threat of 
violence, women may have a lower self-perception of their HIV risk, which can 
impact adherence for novel HIV prevention strategies, such as pre-exposure-
prophylaxis (PrEP) (Van Damme, et al, 2012). Many reports have identified 
pathways by which violence increases women’s risk for HIV-acquisition, 
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including forced sex with an HIV-positive partner, having unprotected sex out of 
fear of violence or abuse, and engaging in risky behaviors that may be related to 
trauma from childhood abuse (Gielen et al., 2000 & 2005; Maman, 2002). In 
addition, research finds that HIV-positive women may fear intimate partner abuse 
or domestic violence upon disclosure of an HIV diagnosis (Rothenberg, 1995; 
Zierler et al., 2000 & 1996; Vlahov et al., 1998; Gielen et al., 2000a & 2000b). 
Although there are HIV prevention methods currently in development that women 
feasibly could control themselves--such as microbicides and oral PrEP—(which 
may mitigate HIV acquisition risk and allow women to use prevention methods 
discreetly, if they wish), more research (and more time) will provide further 
insight into the efficacy of these approaches.  
 Exposure to sexual violence has been identified as a risk factor for 
women and HIV acquisition. Women who are sexually abused are more likely to 
contract HIV (Zierler, 1996; Dunkle et al., 2004; Ehrhardt et al., 2002; WHO, 
2010). Researchers have identified a “continuum of risk” that begins with 
childhood abuse and leads to a lifetime of susceptibility to greater risk-taking: 
such as sexual promiscuity; illicit drug use, vulnerability to rape; multiple 
partners; and partners who also use drugs (Lichtenstein, 2005). 
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Table 1. Lifetime Prevalence of Rape, Physical Violence, and/or Stalking by an 
Intimate Partner, by Race/Ethnicity − U.S. Women, National Intimate Partner and 
Sexual Violence Survey 2010 
Non-Hispanic  
 
Hispanic Black White 
Asian or 
Pacific 
Islander 
American 
Indian or 
Alaskan 
Native 
Multi-
racial 
Rape Weighted 
% 8.4 12.2 9.2 * * 20.1 
Physical 
Violence 
Weighted 
% 35.2 40.9 31.7 * 45.9 50.4 
Stalking Weighted 
% 10.6 14.6 10.4 * * 18.9 
Rape, 
physical 
violence, 
and/or 
stalking 
Weighted 
% 
37.1 43.7 34.6 19.6 46.0 53.8 
HIV 
Prevalence 
Rate 
All 
women: 
25%; 
% of all 
women 
17 64 15 1 .7 * 
 Race/ethnicity was self-identified. The American Indian or Alaskan native 
designation does not indicate being enrolled or affiliated with a tribe. 
* Estimate is not reported. 
 CDC Surveillance Report, 2009. 
 
These risk factors are even more prominent among young women and women of 
lower socio-economic status, who are more likely to depend on their male 
partners for financial security and engage in high-risk behaviors such as trading 
sex for money, drugs or shelter (CDC 2013, El-Bassel et al 2005).   
Research has also found that physical violence/beatings, verbal abuse, 
rape, or sexual coercion correlate with HIV risk (El-Bassel et al, 2005). Both 
overt and covert threats of violence pressure women to engage in unsafe practices 
they might otherwise not engage in were violence not a factor in their lives, 
directly impacting risk of HIV acquisition. For example, women with abusive 
partners may be afraid to ask them to use condoms out of fear their partners will 
see such a request as a question about their fidelity or trustworthiness (See 
Kalichman, 2005; Wingood, 1997; Lichtenstein, 2005; Zierler, 1996). Condom 
use is a crucial HIV prevention tool, particularly when it is estimated that 80% of 
women contract HIV from high-risk heterosexual contact (CDC, 2011). 
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The public health and social-behavioral research discussed above explores 
violence as a risk factor in HIV acquisition. However, many current HIV research 
protocols do not fully address violence. Screening and intake forms often do not 
include questions about violence, even though this discussion often occurs 
between clinicians and patients. For example, in the HIV Vaccine Trials Network 
(HVTN), only two protocols—both of which were observational—included 
questions about sexual victimization (personal communication with network 
representatives). “Risk”, in the context of clinical trials, is often assessed by 
obtaining information about sexual practices, partner sexual practices, alcohol and 
drug use drug, and condom use. Existing assessments do not include questions 
that would provide data about the complicated and complex social relationships 
that women must navigate, and the role of violence in those relationships. 
Including questions on case report forms that solicit information about both 
current and prior experiences with sexual and physical violence may capture 
critical insights between violence and drug use, sexual decision-making, risk 
perception and other risk behaviors. There is overwhelming evidence that past 
histories of sexual and physical trauma may have considerable influence on 
present day decision-making around sexual behavior, which is integral to 
understanding the critical links between violence and HIV acquisition for women 
who experience violence (See: Norman et al., 2012; Cavanaugh & Classen, 2009; 
Machtinger et al, 2012).  
 Currently the majority of behavioral and clinical HIV research utilizes 
standardized risk assessment questionnaires that ask individuals to report specific 
HIV risk-related activities—including intravenous drug use, unprotected sex, and 
transactional sex.  Questions generally ask women to report total number of male 
sexual partners and the types of sexual activities engaged in with these partners.   
The WHRC takes the position that this line of questioning creates a situation 
whereby women are overtly or subtly blamed for their HIV infection.  Because of 
unequal power dynamics in individual, familial, communal and societal 
relationships, it is important that risky behaviors are not seen as choices made by 
an individual. For example, women of lower socio-economic status may 
participate in types of transactional unprotected sex due to a perceived lack of 
other options. Female victims of intimate partner violence may participate in risky 
sex with their partner if they depend on that partner for food, shelter and support 
(Lichtenstein, 2005). This reflects only a fraction of the context in which women 
may not have the ability to make protective choices that prevent HIV infection.  
 
DISCUSSION 
In this position paper, we have argued that the need for better assessment 
procedures that can capture violence in the lives of women. The well-documented 
relationship between violence against women and HIV acquisition among women 
in the U.S. highlights the need for clinical research that considers the role 
violence plays in HIV acquisition and transmission. To this end, the WHRC urges 
the HIV research community to examine the following recommendations for 
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integrating concerns about HIV and violence against women into sponsor- and 
investigator-driven HIV research priorities and clinical trial design. We suggest 
that the HIV research community: 
Allocate resources according to identified national policy priorities. 
According to the National HIV/AIDS Strategy (National HIV/AIDS Strategy, 
2010), additional research is needed into the unique factors that place women at 
risk for HIV infection. In order to address this need, researchers need adequate 
financial and personnel resources to gain greater insight into the unique factors 
that drive the epidemic in the U.S., particularly among women of color. As we 
have discussed, violence is a unique factor that places women at risk for HIV 
infection. Therefore, resources should be allocated for research into violence and 
HIV. Resources should also be allocated such that violence data can be collected 
in clinical and behavioral research.  
Increase solicitations for sponsor- and investigator-driven clinical 
research addressing violence, women, and HIV in the United States.  Early HIV-
prevention interventions tailored for women were based on theoretical models of 
HIV-risk behavioral change that have limited empirical support (Fisher & Fisher, 
2000). Most of these models [e.g., Health Belief Model (Rosenstock, Strecher, & 
Becker, 1988); AIDS risk reduction model (Catania, Kegeles, & Coates, 1990); 
Stages of Change (Prochaska, DiClemente, & Norcross, 1992); Theory of 
Reasoned Action (Fishbein, Middlestadt, & Hitchcock, 1994)] of behavioral risk 
reduction applied to understand risk behaviors did not adequately consider the 
range of important contextual, emotional, and social or real-world factors that 
influence women’s sexual behavior.  Recent HIV prevention strategies have 
drawn from more gender sensitive theories such as the Theory of Gender and 
Power (Connell, 1987), the Ecological Model (Bronfenbrenner, 1979), Social 
Cognitive Theory (Bandura, 1994) and a Modified AIDS Risk Reduction Model 
(M-ARRM) (Miller, Exner & Williams, et al., 2000). These allow structural 
factors specific to women’s experience to be addressed. An increase in gender 
sensitive research can better account for the role of violence in women’s lives, in 
the risk of HIV acquisition, and in disease progression. If violence is made a 
research priority, we will be better able to identify strategies to ameliorate this 
problem.  
Craft research questions that acknowledge complex social relationships 
and power dynamics. It is important that researchers consider the social and 
cultural context in which they conduct research. Our real-world experience leads 
us to conclude that female study participants navigate unique community, family, 
and interpersonal relationships with deeply embedded power dynamics that affect 
their risk for HIV acquisition and transmission. Therefore, researchers should 
consider and integrate each level of these relationships into study design. A better 
understanding of women’s social relationships and the power dynamics attendant 
in these relationships will allow research to reach more accurate conclusions 
about risk, acquisition, and transmission.  
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Revise risk assessments to collect data on gender-based violence and 
sexual power dynamics with partners. Including questions on women’s 
experiences with violence may reveal correlations between violence and drug use, 
sexual decision-making, risk perception and other risk behaviors. While 
transactional sex may be an active form of currency for a woman’s financial and 
familial stability, our experience with the NIH clinical trials networks shows us 
that the vast majority of protocols do not screen for this and other indicators 
associated with increased risk for HIV acquisition of transmission (survival sex 
and past histories of sexual and physical trauma) that may have considerable 
influence on present-day decision making around sexual behavior. Therefore, we 
recommend that risk assessments be revised to collect data on violence and sexual 
power dynamics with partners. This data will be important when crafting 
interventions aimed at reducing risk of HIV acquisition as well as risk of violence. 
 
CONCLUSION 
The clear and well-documented relationship between violence, HIV 
acquisition, and the increasing prevalence of HIV in U.S. women raises the 
question of how HIV research can more fully address the relationship to gender-
based violence. Research should ensure that collection and analyses of gender and 
violence are considered and included in research study design wherever possible. 
When violence against women is prioritized in clinical and behavioral HIV 
research, valuable data will continue to emerge. Researchers, health care workers, 
and other stakeholders can then use this data to develop effective, gender-specific 
interventions and address important drivers of the HIV epidemic.  
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